Needham analyst James Ricchiuti maintained a Hold rating on Proto Labs (PRLB – Research Report) today. The company’s shares closed today at ...

GeoVax Labs (GOVX) announced significant progress in advancing Gedeptin as a cancer therapy. Gedeptin, based on a Gene-Directed Enzyme Prodrug ...

Aspargo Labs aims for a direct listing despite minimal revenue, significant losses, and high cash burn. Click here to read an ...

Analyst N. Quinn Bolton notes 2024's divergence in fortunes for semiconductor companies exposed to different end markets. AI ...